logo-loader
Add to MyProactive
VolitionRx - VolitionRx records first revenues from research kits and strengthens balance sheet in third quarter
3 weeks, 5 days ago
CytoDyn - CytoDyn wins IRB approval to give leronlimab to triple-negative breast cancer patients on compassionate grounds
3 weeks, 5 days ago
MRI showing gliblastoma
3 weeks, 6 days ago
Weekend Unlimited Inc. -
3 weeks, 6 days ago
cannabis bud and flower
3 weeks, 6 days ago
Parallax Health Sciences - Parallax Health Sciences Inc subsidiary Parallax Behavioral Health Inc enters into vertical market licenses in financial technology, human resource, lifestyle and healthcare fields
3 weeks, 6 days ago
Patented stamp
3 weeks, 6 days ago
CytoDyn - CytoDyn Inc reports positive results from first patient in triple-negative breast cancer drug leronlimab trial
3 weeks, 6 days ago
hemp field
4 weeks ago
ROTH Capital Partners - Roth reiterates Buy rating on Seelos Therapeutics as study of SLS-002 advances
4 weeks ago
CB2 Insights Inc posts record 3Q revenue of C$4.2M boosted by strategic acquisitions
on 11/08/2019
Pills in packaging
on 11/08/2019
Orgenesis - Orgenesis Inc sees fiscal 3Q revenue shoot up by 46% to a record $9.1 million
on 11/08/2019
drake
on 11/07/2019
Acasti Pharma Inc -
on 11/07/2019
Acasti Pharma Inc -
on 11/07/2019
Humanigen Inc - Humanigen’s promising studies on lenzilumab to be presented at the American Society of Hematology
on 11/06/2019
Zynerba Pharmaceuticals - Zynerba logs productive 3Q, on track to report top-line results from CONNECT-FX study with Zygel CBD gel in 2020
on 11/06/2019
cells
on 11/05/2019
Cannabis in front of the Canadian flag
on 11/05/2019